Innocens BV leverages IBM Technology to Develop an AI Solution to help detect potential sepsis events in high-risk newborns
IBM Big Data Hub
MARCH 7, 2023
We joined forces with a Bio-informatics research group from the University of Antwerp and started taking the first steps in developing a solution. The impact of the Innocens technology is being investigated in clinical trials and is not yet commercially available.
Let's personalize your content